@peter_brit "And the personnel that we have who have been working in these consulting capacities..So that right there is already the first immediate expansion of the management team, and we have more on our radar screen, and that of course includes succession aspects"
@peter_brit In $NWBO ASM on Dec 2025, LP said "and if we receive an approval, they will just step seamlessly into doing the same role, but as an employee of Northwest"
❤️🙏 ANOTHER MRI. ANOTHER ANSWERED PRAYER!
NO EVIDENCE OF DISEASE!!! 🎉❤️
Today, Braelyn had another brain MRI, and I am absolutely OVERJOYED to share that it once again showed NO EVIDENCE OF DISEASE!
NO CHANGE from her August MRI!
And just FOUR DAYS AGO, on Friday, November 6, Braelyn received her 5th DCVax-L treatment in London! 🇬🇧
I cannot begin to describe the emotions.
After more than three years of fighting this devastating brain cancer, three major brain tumor surgeries, radiation, countless treatments, and more fear than I ever imagined a mother could endure, we are now celebrating another MRI showing NO EVIDENCE OF DISEASE!
I wish I could tell you that the scanxiety gets easier. But it doesn’t. At least not for me.
Every MRI brings back the memories of devastating scans, heartbreaking news, and the terrifying uncertainty of what might come next.
I still find myself holding my breath, praying desperately for those words.
And today, we heard them again.
NO EVIDENCE OF DISEASE. ❤️🙏
My heart is overflowing with gratitude.
To every single person who has prayed for Braelyn, supported our family, donated to help make her treatments possible, shared her story, or simply sent us words of encouragement—THANK YOU!
You have helped carry us through the darkest days of our lives, and you are now helping us celebrate some of the brightest.
And to Northwest Biotherapeutics ($NWBO), the brilliant Dr. Linda Liau at UCLA, and the extraordinary Professor Keyoumars Ashkan at King’s College Hospital—there are simply no words adequate to express our gratitude.
Thank you for your dedication, your compassion, and your determination to bring new hope to patients facing this devastating disease.
Braelyn is 19 years old. She’s attending college. She’s dreaming about her future.
And today, once again, her MRI shows NO EVIDENCE OF DISEASE!
GOD IS GOOD! ❤️🙏
#DCVax #BrainCancer #BraelynsFight #NoEvidenceOfDisease
#DCvaxForBraelyn
❤️🙏 ANOTHER MRI. ANOTHER ANSWERED PRAYER!
NO EVIDENCE OF DISEASE!!! 🎉❤️
Today, Braelyn had another brain MRI, and I am absolutely OVERJOYED to share that it once again showed NO EVIDENCE OF DISEASE!
NO CHANGE from her August MRI!
And just FOUR DAYS AGO, on Friday, November 6, Braelyn received her 5th DCVax-L treatment in London! 🇬🇧
I cannot begin to describe the emotions.
After more than three years of fighting this devastating brain cancer, three major brain tumor surgeries, radiation, countless treatments, and more fear than I ever imagined a mother could endure, we are now celebrating another MRI showing NO EVIDENCE OF DISEASE!
I wish I could tell you that the scanxiety gets easier. But it doesn’t. At least not for me.
Every MRI brings back the memories of devastating scans, heartbreaking news, and the terrifying uncertainty of what might come next.
I still find myself holding my breath, praying desperately for those words.
And today, we heard them again.
NO EVIDENCE OF DISEASE. ❤️🙏
My heart is overflowing with gratitude.
To every single person who has prayed for Braelyn, supported our family, donated to help make her treatments possible, shared her story, or simply sent us words of encouragement—THANK YOU!
You have helped carry us through the darkest days of our lives, and you are now helping us celebrate some of the brightest.
And to Northwest Biotherapeutics ($NWBO), the brilliant Dr. Linda Liau at UCLA, and the extraordinary Professor Keyoumars Ashkan at King’s College Hospital—there are simply no words adequate to express our gratitude.
Thank you for your dedication, your compassion, and your determination to bring new hope to patients facing this devastating disease.
Braelyn is 19 years old. She’s attending college. She’s dreaming about her future.
And today, once again, her MRI shows NO EVIDENCE OF DISEASE!
GOD IS GOOD! ❤️🙏
#DCVax #BrainCancer #BraelynsFight #NoEvidenceOfDisease
#DCvaxForBraelyn
$NWBO #DCVax#Glioblastoma#FDA#Stroke
𝗜𝗳 𝟮𝟲% 𝗜𝘀 𝗡𝗲𝘄𝘀, 𝗪𝗵𝗮𝘁 𝗜𝘀 𝟲𝟴%?
On November 9, FDA approved Sunharbo (asundexian), a pill that lowers the risk of a second stroke by 26%. It was news, and it should be. Now look at a number in brain cancer that is not getting the attention it deserves.
💊 𝗧𝗛𝗘 𝗡𝗨𝗠��𝗘𝗥 𝗧𝗛𝗔𝗧 𝗠𝗔𝗗𝗘 𝗡𝗘𝗪𝗦
OCEANIC-STROKE. 12,327 patients.
Recurrent stroke: 6.2% vs 8.4%.
Hazard ratio 0.74. Risk reduction 26%.
In absolute terms: 2.2 points. About 45 people take the pill to prevent one stroke.
The endpoint was stroke, not death.
The trade-off: major bleeding 1.9% vs 1.7% overall, higher over age 75 and in the first 90 days, plus more gastrointestinal bleeding.
🧠 𝗧𝗛𝗘 𝗡𝗨𝗠𝗕𝗘𝗥 𝗧𝗛𝗔𝗧 𝗦𝗛𝗢𝗨𝗟𝗗
Recurrent glioblastoma kills most patients within a year of relapse.
UCLA's phase 1 trial combined ATL-DC, a vaccine built from the patient's own dendritic cells and the patient's own tumor (the same class as DCVax-L), with poly-ICLC and Keytruda (pembrolizumab). 35 IDH wild type patients. Reported at EANO 2026.
Keytruda before surgery and alongside the vaccine: median survival 271 days.
Vaccine first, then Keytruda: 555 days.
Hazard ratio for death 0.32, p<0.0006.
The endpoint was survival.
Same three drugs. Same disease. Put the vaccine first and the risk of death falls 68%. Survival doubles.
🔬 𝗪𝗛𝗬 𝗧𝗛𝗘 𝗢𝗥𝗗𝗘𝗥 𝗠𝗔𝗧𝗧𝗘𝗥𝗦
Checkpoint inhibitors failed three phase 3 trials in glioblastoma. UCLA's result suggests what was missing: an immune response built first.
Vaccine first: more T cells in the tumor, more interferon and granzyme B.
Keytruda first: chronic inflammatory responses in tumor and blood, and half the survival.
🛡️ 𝗧𝗛𝗘 𝗦𝗔𝗙𝗘𝗧𝗬
The vaccine is the patient's own cells. It is not a blood thinner. It is not chemotherapy.
DCVax-L phase 3: 2,151 doses. 5 serious adverse events judged possibly related, all grade 2 or 3.
No death attributed to the vaccine. No autoimmune reactions. No cytokine storm.
In recurrent glioblastoma, the danger is the disease.
📣 𝗧𝗛𝗘 𝗔𝗧𝗧𝗘𝗡𝗧𝗜𝗢𝗡 𝗜𝗧 𝗗𝗘𝗦𝗘𝗥𝗩𝗘𝗦
A 2.2 point drop in strokes is rightly news. A doubling of survival in one of the deadliest cancers known should be bigger news.
UCLA presents the data at the SNO Annual Meeting on November 14. Every neuro-oncologist, every reporter who covers cancer and every funder of brain tumor research should be reading that abstract.
A result this large deserves a trial large enough to confirm it. Patients with recurrent glioblastoma cannot wait for the field to notice.
Made in America. Banned in America.
Braelyn's scans are clear thanks to an American treatment, one she has to fly to the UK to get. In Clemson, she told President Trump her story.
No American should need a passport to get an American treatment. #RightToTry
How personalized vaccines are changing the fight against brain cancer
UCLA researchers are advancing cancer vaccines that train the immune system to recognize and attack brain tumors, offering new possibilities for patients diagnosed with one of the deadliest forms of cancer
https://t.co/golH6LsSVC
How can you argue with $NWBO?
Look
In a 2026 glioblastoma trial, personalized neoantigen-loaded dendritic cells produced up to a 507-fold increase in neoantigen-specific immune responses. All 11 vaccinated patients were alive 12 months after surgery.
https://t.co/Hyc5XKuLA9
AND WITH NO SIGNIFICANT ADVERSE EFFECTS! CHEAPER THAN CHEMO!
If for nothing else - it's easier, faster, and will save on healthcare costs to patients and to the government! The data is there, the proof is breathing and posting on X, the promise is enormous.
There are only two reasons to NOT move the machinery of the U.S. government to approve this in the next 3 months: Indifference to humanity, Allegiance to Big Pharma profits.
@DrOzCMS@SecKennedy, Be the leaders who make this happen.
#nwbo
#dcvax
#rarecancers
$NWBO
A British politician welcomed @HollensbeBrae and @HollensbeAmanda before the UK Parliament
Labour MP @SharonHodgsonMP said patients like Braelyn should have more access to @NorthwestBio’s DCVax platform.
She told the House of Commons how Braelyn has to fly from South Carolina to London for DCVax, because she still can’t get the promising glioblastoma treatment in the U.S.
Braelyn is in the UK for her 5th dose of DCVax.
Hodgson pointed out DCVax’s effectiveness and highlighted Braelyn’s latest MRI showing “No Evidence Of Disease”.
DCVax is a Phase III treatment with promising results for all solid tumors, including glioblatoma.
This is a session that happens on Wednesdays in the UK lawmakers question the government in a session called PMQs - Prime Minister’s Questions
Thanks @jaygreco194737 for the clip
@andrewcaravello@BenHollensbe@SpimacoAddwaeih@aljedai@MHRAgovuk@UCLAStrokeNSG@KCHLSAUDI@NHSEngland@NHSBT@DrOzCMS@FDA
#NWBO
Northwest Biotherapeutics getting a massive shout-out in the UK Parliament today.
Surely this will get approved as a therapy by MHRA now it is confirmed that Andy Burnham is taking a personal interest.
I am thinking about buying a little bit more - I have tipped NWBO as one of my two highest conviction trades.
@peter_brit Particularly interesting that Braelyn got the invite to Parliament via the NHS. Given she isn’t a UK citizen and is privately funding DCVax I find this fact quite extraordinary. I can only infer that the NHS are teeing up DCVax to be a major part of their cancer strategy! $NWBO
What an absolute honor to have been invited to sit in the Speaker’s VIP box. A huge Thank You to Sharon Hodgson, Labour MP for highlighting this very important issue affecting so many people in both of our countries, and beyond. We are grateful for the warm reception and the support of our “cousins” on the other side of the pond!
#DcVaxForBraelyn
@DrOzCMS
$NWBO #DCVaxForBraelyn
A registry of off-label guesses is an admission nobody knows the target. Dendritic cells loaded with a patient's own tumor never need it. They find it, rank it and build the response. Dendritic cells do bioinformatics for a living. Phase 3 is published. #DCVax is already on FDA's own docket, FDA-2026-N-12214. Approve it.
$NWBO #DCVAX
Dr. Oz, behind every clinical trial are real people fighting for their lives. Mothers, fathers, sons and daughters who simply want more time…
DCVax-L has published Phase III results, documented long-term survivors exceeding 20 years, and a remarkably favorable safety profile. Its potential extends beyond brain cancer to a much broader platform potentially targeting all solid tumors.
Every single day… approximately 680 people worldwide lose their lives to GBM and CNS cancers alone. That’s one life every two minutes. These patients don’t have the luxury of waiting years for promising treatments to become accessible.
Right to Try should mean something. Nobody is asking to compromise science or safety. We’re asking for urgency, compassion and access for patients who have exhausted their options.
Innovation means nothing if it never reaches the people who need it most.
To a cancer patient, time isn’t money. Time is everything.
Dr. Oz, please help bring DCVax to American patients. They deserve a fighting chance.
Patients with rare diseases need better access to lifesaving treatments.
At the Cleveland Clinic, @CMSGov and the @FDA announced coordinated action to cut red tape, lower costs, and expand access to cell and gene therapies.
Innovation only matters when it reaches patients.
$NWBO ain’t the only company waiting on Judge Stein’s algo ruling. Not even close.
The defendants run the same systems across thousands of names, including many OTC and smaller stocks. Genius Group and Meta Materials already sued the same firms for spoofing.
If the court orders production and the code shows the order patterns NWBO alleges, other companies get a real roadmap.
That alone is enough to make at least some of the defendants start looking for a way out. ie Settlements.
For Kenny G & the Spoofers, this fight ain't about one lawsuit. It��s about stopping the exposure from spreading.
My Dad used to tell me in my formative years that, “The cream will always rise to the top”. I got the analogy, but now at age 50, I fully understand it. Take @NorthwestBio a small biotech company that created a scientific breakthrough in personalized immunotherapy. They didn’t create this lifesaving treatment for political reasons, they did it for the patients. Dr. Linda Liau’s mother passed away from a cancer that spread to her brain. The C.E.O Linda Powers (correct me if I’m wrong) father passed away from a Glioblastoma.
What I’m saying is they made the DCVax out of compassion not vindication. Passion over power. That is why no matter how much money 💰 you spend to try & suppress it, it never goes away. Just like the late great Les Goldman said when you’ve got the recipe for @CocaCola you want to hold on to it. Sorry big pharma you’re not gonna shelf this juggernaut. It’s beyond comprehension that human beings would let this breakthrough go unapproved. Yet here we are… Not approved; first by our own @FDA after three successful trials. Then the @MHRAgovuk hasn’t approved it after roughly 3 years since submission. Despite building infrastructure to produce the PERSONALIZED VACCINE 💉 in mass. Why do people value money 💵 more than life, you can’t hug money.
Again, if you’re aiding anyone that’s responsible in this effort to destroy NWBO & the DCVax, you are still complicit in the deaths of countless innocents. You just don’t know it yet.
@kshaughnessy2@LisainNJUSA@HollensbeAmanda@ElvirPons@TheLastWord@LastWeekTonight@DCVaxDefender@ablidy@DontheConDrumpf@stephmase22@Clairotonin@andrewcaravello@rjmsoflo@EatYerShorts@TomBaxers@maddenifico@RepThomasMassie@BernieSanders@SenSanders@mcuban